Catalent’s oral solid dose manufacturing solutions are built on a proven track record of successful scale-up manufacturing processes and technology transfers. Our product launch expertise, special handling ability, and flexible capacity accommodate unique program requirements whether an orphan drug or a blockbuster. By leveraging expertise and scale across a global network, Catalent matches the best technologies to optimal dose forms to enable successful programs.
Our capabilities include:
- End-to-end spray drying solutions
- OptiPact™ roller compaction
- OptiMelt® hot melt extrusion
- Zydis® orally-disintegrating tablet technology
- R.P. Scherer® softgel
- Highly potent and controlled substance handling
- Dedicated suites for unique program requirements
Spray Drying Technology
We have 20 R&D teams with development and formulation expertise to help solve some of the most complex bioavailability challenges. With over 85 years of experience and multiple, proven and innovative formulation technologies to help you deliver more effective treatments that can improve the performance of your product. Catalent can help overcome complex bioavailability challenges and accelerate drug development process through superior formulation technologies and rigorous data-driven scientific approach, which has evolved by our global research and development teams with a successful track record of optimizing thousands of molecules using the widest variety of advanced and proven formulation technologies in the industry.
Opimelt Hot Melt Extrusion
Optiform Solution Suite
Sr. Account Director, Early Phase Development, Oral Development and Delivery
Senior Account Director, Particle Engineering, Oral & Specialty Delivery
Account Executive, Oral & Specialty Delivery
Business Development Associate
Director of Scientific Services
Connect with the right expert now. Tell us your challenge and we’ll get back to you within 24 hours.
14 Schoolhouse Road
Somerset, NJ 08873
Oops! We could not locate your form.